{
    "Trade/Device Name(s)": [
        "BreathID Smart System",
        "BreathID Hp Lab System"
    ],
    "Submitter Information": "Exalenz Bioscience Ltd.",
    "510(k) Number": "K193610",
    "Predicate Device Reference 510(k) Number(s)": [
        "K173777"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "MSQ",
        "JJQ"
    ],
    "Summary Letter Date": "February 6, 2020",
    "Summary Letter Received Date": "December 26, 2019",
    "Submission Date": "December 22, 2019",
    "Regulation Number(s)": [
        "21 CFR 866.3110"
    ],
    "Regulation Name(s)": [
        "Campylobacter fetus serological reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "13CO2/12CO2 ratio",
        "Helicobacter pylori"
    ],
    "Specimen Type(s)": [
        "Exhaled breath"
    ],
    "Specimen Container(s)": [
        "Breath sample bag"
    ],
    "Instrument(s)/Platform(s)": [
        "BreathID Smart device",
        "BreathID Hp device",
        "Auto Sampler"
    ],
    "Method(s)/Technology(ies)": [
        "Molecular Correlation Spectroscopy (MCS)",
        "Infrared spectrometry"
    ],
    "Methodologies": [
        "Spectroscopy",
        "Optical absorption measurement"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "System",
        "Test kit",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for BreathID Smart System\u2014a noninvasive breath test system using molecular correlation spectroscopy for Helicobacter pylori detection via 13CO2/12CO2 breath analysis.",
    "Indications for Use Summary": "Aids in initial diagnosis and post-treatment monitoring of Helicobacter pylori infection in adults and children (3-17 years), measuring 13CO2/12CO2 ratio in exhaled breath non-invasively, for prescription use by trained personnel.",
    "fda_folder": "Microbiology"
}